Back to results
RecruitingPhase 2

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

NCT06518720

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centre for Addiction and Mental Health

Toronto, Ontario, Canada

Contact

Emily Gilbert, MSc

4165358501emily.gilbert@camh.ca
View on ClinicalTrials.gov
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND) — TrialFind